Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Every row

Showing 15 of 382 rows for Cost of dementia care. One row per study per exposure: a study that tested two different things appears twice, once for each.

Scroll the table sideways to see every column.

Research and outcomes, 15 rows. Every row links to its source.
Exposure Question Direction Outcome measured Design People Effect size, as the source reported it Source
Cost of dementia care Care, carers and services Treatment No direction reported
why

A cost estimate ($818 billion, 80% of it borne by families through unpaid care, earnings losses, out-of-pocket costs and quality-of-life losses) with no exposure compared, so no direction is recorded.

Total cost of dementia in the United States in 2026 modelling study not stated In 2026, 5.7 million (95% confidence interval [CI] [5.6, 6.0]) US adults aged 51 and older are living with dementia, supported by 5.2 million (95% CI [4.9, 5.5]) care partners. Total costs are $818 billion (B, 95% CI [759, 866]), driven by quality-of-life losses for persons with dementia ($320B, 95% CI [269, 363]) and care partners ($15B 95% CI [6, 25]). Unpaid care ($237B, 95% CI [220, 253]), earnings losses ($23B), and out-of-pocket costs combined with quality-of-life losses account for 80% of costs and are borne by families Alzheimer's & Dementia 2026
✓ Peer-reviewed PMID 42340126
Cost of dementia care Care, carers and services Treatment No direction reported
why

A descriptive spending analysis with no exposure compared, so there is no direction to record: Part D spending rose with dual-eligibility duration, Part B drug spending varied widely by state, and ACO enrollment made only a modest difference.

Medicare Part D and Part B drug spending and out-of-pocket costs among fee-for-service beneficiaries with dementia, by dual eligibility, state and ACO enrollment cross-sectional study 1,372,696 Medicare Part D drug spending was substantial, increasing with dual-eligibility duration: $8732-$9107 among beneficiaries with full-year dual eligibility and exceeding $11 500 among those with 5+ chronic conditions ... Medicare Part B drug spending was highest among Medicare-only beneficiaries and varied widely by state, ranging from $433 to $1827 among Medicare-only beneficiaries and from $179 to $1446 among dually eligible beneficiaries Innovation in Aging 2026
✓ Peer-reviewed PMID 42787606
Cost of dementia care Care, carers and services Treatment Harm
why

Direction is for having AD dementia: lifetime formal-care costs of 2,440,000 SEK against 510,000 SEK for matched controls, with prescriptions and social care rising and specialist outpatient visits falling as the disease advanced. A cost result, not a health outcome.

Lifetime formal-care costs after an AD dementia diagnosis versus matched controls, and care utilization by stage cohort study 20,366 The estimated lifetime costs of formal care for AD dementia were 2,440,000 SEK (€212,174; $US230,189; 95% CI 2,088,000-2,793,000 SEK), compared with 510,000 SEK (€44,348; $US48,113; 95% CI 482,000-539,000 SEK) for matched controls PharmacoEconomics 2026
✓ Peer-reviewed PMID 41920501
Cost of dementia care Care, carers and services Treatment No direction reported
why

A cost projection: total burden is estimated at $344 billion in 2020 rising to over $3 trillion in 2060, with African American and Latino families projected to bear a disproportionate share. It compares spending shares between groups but tests no exposure, so no direction is recorded.

Total US economic burden of dementia by race and ethnicity, 2020 to 2060 modelling study 31,028 The total estimated economic burden of ADRD was close to $344 billion in 2020 and was projected to increase to over $3 trillion in 2060. African American and Latino adults bore one-third ($113 billion) of it in 2020, with projections rising to $1.7 trillion by 2060, surpassing the economic burden for White adults, which was projected to grow from $231 billion to $1.4 trillion JAMA Network Open 2025
✓ Peer-reviewed PMID 40471578
Cost of dementia care Care, carers and services Treatment No direction reported
why

A cost estimate with no exposure compared, so there is no direction to record. Higher unpaid-care costs went with lower medical spending on nursing facility care.

Annual cost of care attributable to dementia per case in 2019 and the unpaid-care share of total cost by US state modelling study not stated The annual cost of care attributable to dementia in 2019 was $53,502 (95% uncertainty interval [UI] 46,135-60,594) per case. The contribution of unpaid care to total costs varied by state, ranging from 70.2% (95% UI 64.3-75.4) in the District of Columbia to 89.9% (95% UI 87.8-91.5) in Arizona Journal of Alzheimer's Disease 2025
✓ Peer-reviewed PMID 40111940
Cost of dementia care Care, carers and services Treatment No direction reported
why

A cost projection with no exposure compared, so there is no direction to record. Dementia's share of replacement cost is projected to rise from 44% to 53%.

Replacement cost of unpaid family care and opportunity cost of forgone earnings for older Americans with and without dementia, now and projected to 2060 modelling study not stated Current annual replacement cost of unpaid family care is between $96 and $182 billion, 44% of which is accounted for by dementia caregiving. By 2060, it will increase to $277-571 billion, and 53% will be for dementia caregiving. The opportunity costs of forgone earnings and productivity loss, however, will grow faster, increasing from current levels of $107 billion and $26 billion to $380 billion and $102 billion, respectively, in 2060 Innovation in Aging 2025
✓ Peer-reviewed PMID 40662057
Cost of dementia care Care, carers and services Treatment No direction reported
why

A cost estimate with no exposure compared, so there is no direction to record.

Annual indirect cost of Alzheimer's disease per person by severity, and total US indirect cost modelling study not stated $36 934 for mild cognitive impairment owing to AD, $65 565 for mild AD, $103 717 for moderate AD, and $145 250 for severe AD (2024 United States Dollars [USD]). Considering the current distribution of prevalent patients across severity stages, the total annual indirect cost was estimated at $832 billion, which includes $599 billion in unpaid caregiving costs and $233 billion in productivity losses Value in Health 2025
✓ Peer-reviewed PMID 39571734
Cost of dementia care Care, carers and services Treatment Harm
why

Direction is for greater disease severity: mean annual costs rose from SEK 99,906 in MCI to SEK 795,617 in severe AD (SEK 57,625 to 668,073 in the amyloid-confirmed subset), driven by institutionalisation, home care and daytime support while outpatient costs fell. A cost result, not a health outcome.

Mean annual direct medical and social costs by AD severity (MCI to severe), overall and in amyloid-confirmed patients, versus matched controls cohort study 95,853 Mean annual costs for individuals with clinically diagnosed AD were SEK 99,906, SEK 290,972, SEK 479,524, and SEK 795,617 in mild cognitive impairment (MCI), mild, moderate, and severe AD. The mean annual costs for the population with both clinical diagnosis and amyloid-positive AD confirmation (N = 5610) were SEK 57,625, SEK 179,153, SEK 333,095, and SEK 668,073 in MCI, mild, moderate, and severe AD, respectively PharmacoEconomics 2025
✓ Peer-reviewed PMID 39485581
Cost of dementia care Care, carers and services Treatment Harm
why

Direction is for being on the Alzheimer's continuum: societal costs were 52% higher in subjective cognitive decline, 170% in MCI and 307% in AD dementia than in controls, and payer costs 26%, 85% and 36% higher. A cost result, not a health outcome.

Excess annual costs from payer and societal perspectives in subjective cognitive decline, MCI and AD dementia versus controls cross-sectional study not stated From a payer perspective, costs were elevated by 26% for SCD (adjusted mean 5,976€ [95%CI 4,598-7,355€]), 85% for MCI (8,795€ [6,200-11,391€]) and 36% for AD (6,454€ [2,796-10,111€]) compared to controls (4,754€ [3,586-5,922€]). Societal costs were elevated by 52% for SCD (adjusted mean 8,377€ [95%CI 6,009-10,746€]), 170% for MCI (14,886€ [9,524-20,248€]) and 307% for AD (22,481€ [9,994-34,969€]) compared to controls (5,522€ [3,814-7,230€]) Alzheimer's research & therapy 2025
✓ Peer-reviewed PMID 40571933
Cost of dementia care Care, carers and services Treatment No direction reported
why

A cost estimate and projection with no exposure compared, so there is no direction to record.

Per-patient cost of care in 2016 and aggregate US cost projected 2020-2060 modelling study not stated In 2016, the estimated per patient cost of formal care was $28,078 (95% confidence interval [CI]: $25,893-$30,433), and informal care cost valued in terms of replacement cost and forgone wages was $36,667 ($34,025-$39,473) and $15,792 ($12,980-$18,713), respectively. Aggregate formal care cost and formal plus informal care cost using replacement cost and forgone wage methods were $196 billion (95% uncertainty range [UR]: $179-$213 billion), $450 billion ($424-$478 billion), and $305 billion ($278-$333 billion), respectively, in 2020. These were projected to increase to $1.4 trillion ($837 billion-$2.2 trillion), $3.3 trillion ($1.9-$5.1 trillion), and $2.2 trillion ($1.3-$3.5 trillion), respectively, in 2060 npj Aging 2024
✓ Peer-reviewed PMID 38331952
Cost of dementia care Care, carers and services Treatment No direction reported
why

A cost estimation across 204 countries with no exposure compared, so there is no direction to record.

Global direct health care spending and informal care cost attributable to dementia, 2019, with projection to 2050 modelling study not stated in 2019, the direct health care spending attributable to ADRD across 204 countries reached $260.6 billion (95% uncertainty interval [UI] 131.6-420.4) and the cost of informal ADRD care was $354.1 billion (95% UI 190.0-544.1). On average, informal care represents 57% (95% UI 38-75%) of the total cost of care. We estimated that direct health care spending attributable to ADRD will reach $1.6 trillion (95% UI 0.6-3.3) in 2050, or 9.4% (95% UI 3.9-19.6%) of projected health spending worldwide Journal of Alzheimer's Disease 2024
✓ Peer-reviewed PMID 39150827
Cost of dementia care Care, carers and services Treatment Harm
why

Direction is for being non-Hispanic Black or Hispanic rather than non-Hispanic White: disease-course Medicare spending was higher ($165,730 and $160,442 versus $136,326), highest for Black beneficiaries in every phase and driven by high-cost services in the last year of life. A disparities result, not a biological effect of race.

Disease-course Medicare expenditures (year before diagnosis to last year of life) by race and ethnicity cohort study not stated Adjusted mean total Medicare expenditures for non-Hispanic (NH) Black ($165,730) and Hispanic beneficiaries with dementia ($160,442) exceeded corresponding expenditures for NH Whites ($136,326) ... The last year of life was responsible for the greatest cost contribution: $51,294 (NH Blacks), $47,469 (Hispanics), and $39,499 (NH Whites) Journal of the American Geriatrics Society 2024
✓ Peer-reviewed PMID 38504583
Cost of dementia care Care, carers and services Treatment Harm
why

Direction is for dying with dementia rather than heart disease, cancer or other causes: total cost was higher ($287,038) and out-of-pocket spending 81% higher, consuming 32% of household wealth versus 11%.

Total social cost and out-of-pocket spending in the last 5 years of life cohort study 1,702 Average total cost per decedent with dementia ($287 038) was significantly greater than that of those who died of heart disease ($175 136), cancer ($173 383), or other causes ($197 286) (P < 0.001). Although Medicare expenditures were similar across groups, average out-of-pocket spending for patients with dementia ($61 522) was 81% higher than that for patients without dementia ($34 068) Annals of Internal Medicine 2015
✓ Peer-reviewed PMID 26502320
Cost of dementia care Care, carers and services Treatment Harm
why

Direction is for living in the community rather than a nursing home: unadjusted costs were lower in the community, but after adjusting for functional impairment and comorbidity community care cost €11,344 more per year, mainly through informal care. A cost result, not a health outcome.

Annual societal cost of care, community-dwelling versus nursing home residents cross-sectional study 176 Unadjusted mean annual total costs including informal care were €29,930 ($43,997) for community-dwelling patients and €33,482 ($49,218) for patients living in nursing homes. However, multiple regression analysis controlling for age, sex, deficits in basic and instrumental activities of daily living and comorbidity showed that living in the community significantly increased total costs by €11,344 ($16,676; P < .01) compared with living in a nursing home, mainly due to higher costs of informal care (+€20,585; +$30,260; P < .001) Journal of the American Medical Directors Association 2014
✓ Peer-reviewed PMID 24321877
Cost of dementia care Care, carers and services Treatment Harm
why

Direction is for having dementia: the attributable yearly cost per person was $41,689-$56,290 depending on how informal care is valued, a burden the authors call similar to heart disease and cancer.

Yearly monetary cost per person attributable to dementia, and total US cost in 2010 cohort study 10,903 The yearly monetary cost per person that was attributable to dementia was either $56,290 (95% confidence interval [CI], $42,746 to $69,834) or $41,689 (95% CI, $31,017 to $52,362), depending on the method used to value informal care. These individual costs suggest that the total monetary cost of dementia in 2010 was between $157 billion and $215 billion. Medicare paid approximately $11 billion of this cost New England Journal of Medicine 2013
✓ Peer-reviewed PMID 23550670

How this table was built, and where it is weak →

Last updated